Annual Accounts Payable
$6.51 M
+$987.00 K+17.86%
31 December 2023
Summary:
UroGen Pharma annual accounts payable is currently $6.51 million, with the most recent change of +$987.00 thousand (+17.86%) on 31 December 2023. During the last 3 years, it has risen by +$3.24 million (+99.14%). URGN annual accounts payable is now at all-time high.URGN Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$5.56 M
-$2.76 M-33.20%
30 September 2024
Summary:
UroGen Pharma quarterly accounts payable is currently $5.56 million, with the most recent change of -$2.76 million (-33.20%) on 30 September 2024. Over the past year, it has increased by +$1.51 million (+37.49%). URGN quarterly accounts payable is now -33.20% below its all-time high of $8.32 million, reached on 30 June 2024.URGN Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
URGN Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.9% | +37.5% |
| 3 y3 years | +99.1% | +36.9% |
| 5 y5 years | +52.5% | +110.6% |
URGN Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +99.1% | -33.2% | +126.1% |
| 5 y | 5 years | at high | +99.1% | -33.2% | +126.1% |
| alltime | all time | at high | +277.0% | -33.2% | +226.8% |
UroGen Pharma Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.56 M(-33.2%) |
| June 2024 | - | $8.32 M(+32.9%) |
| Mar 2024 | - | $6.26 M(-3.9%) |
| Dec 2023 | $6.51 M(+17.9%) | $6.51 M(+61.2%) |
| Sept 2023 | - | $4.04 M(-13.3%) |
| June 2023 | - | $4.66 M(-33.1%) |
| Mar 2023 | - | $6.97 M(+26.1%) |
| Dec 2022 | $5.53 M(-4.5%) | $5.53 M(+117.2%) |
| Sept 2022 | - | $2.54 M(+3.6%) |
| June 2022 | - | $2.46 M(-42.0%) |
| Mar 2022 | - | $4.23 M(-26.8%) |
| Dec 2021 | $5.79 M(+76.9%) | $5.79 M(+42.5%) |
| Sept 2021 | - | $4.06 M(-15.9%) |
| June 2021 | - | $4.83 M(-20.8%) |
| Mar 2021 | - | $6.10 M(+86.4%) |
| Dec 2020 | $3.27 M | $3.27 M(-20.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $4.13 M(-10.1%) |
| June 2020 | - | $4.60 M(+10.7%) |
| Mar 2020 | - | $4.15 M(-11.5%) |
| Dec 2019 | $4.69 M(+9.9%) | $4.69 M(+77.9%) |
| Sept 2019 | - | $2.64 M(+25.6%) |
| June 2019 | - | $2.10 M(+23.6%) |
| Mar 2019 | - | $1.70 M(-60.2%) |
| Dec 2018 | $4.27 M(+50.5%) | $4.27 M(-32.1%) |
| Sept 2018 | - | $6.29 M(+11.2%) |
| June 2018 | - | $5.66 M(+39.7%) |
| Mar 2018 | - | $4.05 M(+42.6%) |
| Dec 2017 | $2.84 M(+51.0%) | $2.84 M(-18.6%) |
| Sept 2017 | - | $3.49 M(-1.6%) |
| June 2017 | - | $3.54 M(+88.5%) |
| Dec 2016 | $1.88 M(+8.8%) | $1.88 M |
| Dec 2015 | $1.73 M | - |
FAQ
- What is UroGen Pharma annual accounts payable?
- What is the all time high annual accounts payable for UroGen Pharma?
- What is UroGen Pharma annual accounts payable year-on-year change?
- What is UroGen Pharma quarterly accounts payable?
- What is the all time high quarterly accounts payable for UroGen Pharma?
- What is UroGen Pharma quarterly accounts payable year-on-year change?
What is UroGen Pharma annual accounts payable?
The current annual accounts payable of URGN is $6.51 M
What is the all time high annual accounts payable for UroGen Pharma?
UroGen Pharma all-time high annual accounts payable is $6.51 M
What is UroGen Pharma annual accounts payable year-on-year change?
Over the past year, URGN annual accounts payable has changed by +$987.00 K (+17.86%)
What is UroGen Pharma quarterly accounts payable?
The current quarterly accounts payable of URGN is $5.56 M
What is the all time high quarterly accounts payable for UroGen Pharma?
UroGen Pharma all-time high quarterly accounts payable is $8.32 M
What is UroGen Pharma quarterly accounts payable year-on-year change?
Over the past year, URGN quarterly accounts payable has changed by +$1.51 M (+37.49%)